cd27 (Miltenyi Biotec)
Structured Review
Cd27, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 59 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd27/CD27+Antibody%2C+anti-human%2Fmouse%2C+REAfinity/pm42455847-67-25-29
Average 94 stars, based on 59 article reviews
Images
Related Articles
Staining:Article Title: A novel Vδ1 engager targeting CD19 enhances human Vδ1 γδ T cell responses against CLL and CD19+ hematological malignancies. Article Snippet: γδ T cells are associated with favorable outcomes in many cancers likely through a mechanism of stress-directed cytotoxicity and antitumor cytokine production.. Vδ1 γδ T cells are especially promising for immunotherapy due to their broad stress recognition and resistance to activation-induced cell death.. Here, we generate a CD19 engager incorporating a novel Vδ1 binding moiety as proof-of-concept for treating CD19 cancers, including Chronic Lymphocytic Leukemia (CLL). Article Title: Early-stage B cells predict relapse after rituximab treatment in patients with Membranous Nephropathy Article Snippet: .. To characterize B-cell subsets, peripheral blood mononuclear cells were stained with fluorochrome-conjugated monoclonal antibodies (BD Biosciences) directed against the following antigens: CD45 (V500-C), CD3 (APC), CD19 (APC-H7), Article Title: Deep Immunoprofiling of Large-Scale Tuberculosis Dataset at Single Cell Resolution Reveals a CD81 bright γδ T Cell Population Associated with Latency Article Snippet: The PBMCs were counted using Trypan blue, transferred to flow cytometry tubes, and then washed with 1 mL of BD staining buffer. .. PBMCs (10 6 cells) were aliquoted into flow cytometry tubes, stained before with Zombie AquaTM Fixable Viability Kit, and then with monoclonal antibodies (mAbs) to CD3 (APC-H7-conjugated, clone SK7, BD Pharmingen TM , BD Bioscience, San Jose, CA, USA), TCR-γδ (PE-conjugated, clone REA591, Miltenyi Biotec, Bologna, Italy), CD81 (APC-conjugated, clone REA513, Miltenyi Biotec, Bologna, Italy), Article Title: Early-Stage B-cells Predict Relapse After Rituximab Treatment in Patients With Membranous Nephropathy Article Snippet: .. To characterize B-cell subsets, peripheral blood mononuclear cells were stained with fluorochrome-conjugated monoclonal antibodies (BD Biosciences) directed against the following antigens: CD45 (V500-C), CD3 (APC), CD19 (APC-H7), Article Title: Pre‐Vaccination Immunotypes and Immune Entropy Are Indicators of Multiple Vaccine Responsiveness Article Snippet: .. PBMCs from kidney transplant recipients participating in the RECOVAC cohort were stained using the following anti‐human fluorochrome‐conjugated antibodies: CD3 (Sparkblue 550, SK7, Biolegend), CD4 (cFluor‐YG584, SK3, Cytek), CD8 (BUV805, SK1, BD Biosciences), CD45RA (Spark NIR 685, HI100, Biolegend), CD95 (BB700, DX2, BD Biosciences), HLA‐DR (BV570, L243, Biolegend), CD38 (APC‐Fire810, HIT2, Biolegend), CD19 (eFluor450, HIB19, ThermoFisher), Flow Cytometry:Article Title: A novel Vδ1 engager targeting CD19 enhances human Vδ1 γδ T cell responses against CLL and CD19+ hematological malignancies. Article Snippet: γδ T cells are associated with favorable outcomes in many cancers likely through a mechanism of stress-directed cytotoxicity and antitumor cytokine production.. Vδ1 γδ T cells are especially promising for immunotherapy due to their broad stress recognition and resistance to activation-induced cell death.. Here, we generate a CD19 engager incorporating a novel Vδ1 binding moiety as proof-of-concept for treating CD19 cancers, including Chronic Lymphocytic Leukemia (CLL). Article Title: Deep Immunoprofiling of Large-Scale Tuberculosis Dataset at Single Cell Resolution Reveals a CD81 bright γδ T Cell Population Associated with Latency Article Snippet: The PBMCs were counted using Trypan blue, transferred to flow cytometry tubes, and then washed with 1 mL of BD staining buffer. .. PBMCs (10 6 cells) were aliquoted into flow cytometry tubes, stained before with Zombie AquaTM Fixable Viability Kit, and then with monoclonal antibodies (mAbs) to CD3 (APC-H7-conjugated, clone SK7, BD Pharmingen TM , BD Bioscience, San Jose, CA, USA), TCR-γδ (PE-conjugated, clone REA591, Miltenyi Biotec, Bologna, Italy), CD81 (APC-conjugated, clone REA513, Miltenyi Biotec, Bologna, Italy), Expressing:Article Title: CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphoma. Article Snippet: .. Figure 2: Factors potentially promoting persistence of the zamto-cel CAR-T in our PCNSL patient. (A) Surface expression levels of Bioprocessing:Article Title: Early-stage B cells predict relapse after rituximab treatment in patients with Membranous Nephropathy Article Snippet: .. To characterize B-cell subsets, peripheral blood mononuclear cells were stained with fluorochrome-conjugated monoclonal antibodies (BD Biosciences) directed against the following antigens: CD45 (V500-C), CD3 (APC), CD19 (APC-H7), Article Title: Deep Immunoprofiling of Large-Scale Tuberculosis Dataset at Single Cell Resolution Reveals a CD81 bright γδ T Cell Population Associated with Latency Article Snippet: The PBMCs were counted using Trypan blue, transferred to flow cytometry tubes, and then washed with 1 mL of BD staining buffer. .. PBMCs (10 6 cells) were aliquoted into flow cytometry tubes, stained before with Zombie AquaTM Fixable Viability Kit, and then with monoclonal antibodies (mAbs) to CD3 (APC-H7-conjugated, clone SK7, BD Pharmingen TM , BD Bioscience, San Jose, CA, USA), TCR-γδ (PE-conjugated, clone REA591, Miltenyi Biotec, Bologna, Italy), CD81 (APC-conjugated, clone REA513, Miltenyi Biotec, Bologna, Italy), Article Title: Early-Stage B-cells Predict Relapse After Rituximab Treatment in Patients With Membranous Nephropathy Article Snippet: .. To characterize B-cell subsets, peripheral blood mononuclear cells were stained with fluorochrome-conjugated monoclonal antibodies (BD Biosciences) directed against the following antigens: CD45 (V500-C), CD3 (APC), CD19 (APC-H7), |
